These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8417122)

  • 1. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
    Ying SC; Gewurz AT; Jiang H; Gewurz H
    J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid P component binds to histones and activates the classical complement pathway.
    Hicks PS; Saunero-Nava L; Du Clos TW; Mold C
    J Immunol; 1992 Dec; 149(11):3689-94. PubMed ID: 1431140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
    Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
    J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
    Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
    Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.
    Jiang H; Lint TF; Gewurz H
    Immunology; 1991 Dec; 74(4):725-31. PubMed ID: 1783430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q.
    Veerhuis R; Boshuizen RS; Morbin M; Mazzoleni G; Hoozemans JJ; Langedijk JP; Tagliavini F; Langeveld JP; Eikelenboom P
    Neurobiol Dis; 2005; 19(1-2):273-82. PubMed ID: 15837583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional domains of the human C1q A-chain.
    Trinder PK; Maeurer MJ; Kaul M; Petry E; Loos M
    Behring Inst Mitt; 1993 Dec; (93):180-8. PubMed ID: 8172566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
    García de Frutos P; Dahlbäck B
    J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
    Inforzato A; Peri G; Doni A; Garlanda C; Mantovani A; Bastone A; Carpentieri A; Amoresano A; Pucci P; Roos A; Daha MR; Vincenti S; Gallo G; Carminati P; De Santis R; Salvatori G
    Biochemistry; 2006 Sep; 45(38):11540-51. PubMed ID: 16981714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete cDNA sequence of SAP-like pentraxin from Limulus polyphemus: implications for pentraxin evolution.
    Tharia HA; Shrive AK; Mills JD; Arme C; Williams GT; Greenhough TJ
    J Mol Biol; 2002 Feb; 316(3):583-97. PubMed ID: 11866519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
    Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
    Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.
    Jiang H; Robey FA; Gewurz H
    J Exp Med; 1992 May; 175(5):1373-9. PubMed ID: 1569403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
    J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
    Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
    Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum amyloid P component binds to peripheral blood monocytes.
    Macdonald SL; Kilpatrick DC
    Scand J Immunol; 2006 Jul; 64(1):48-52. PubMed ID: 16784490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
    Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
    J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.